DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
T••••••••• I••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Mar 31, 2024sponsor not established · possible relationship
Also written as: Inc.Investment; Undrawn Commitment
Nothing material in the last 200 days. Last change: 31 Mar 2024, $18.5M principal held by 1 lender; matures Apr 2027.
Mark path, consensus per quarter end
100¢ · 100¢ · 100¢ · 100¢Q2 2023 to Q1 2024
Principal held
at least $18.5M
sum of BDC pieces, a lower bound
Fair value
$36.0M
100c on cost, debt pieces
Unfunded
$500,000
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
2
1 equity pieces beside them
Next maturity
Apr 1, 2027
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Mar 31, 2024
Events
3
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2024, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | $18.5M | 100¢ | 0 pts |
Every BDC piece · 5 positions across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| M••••• F•••••••• I••••••••• C••• | term loan first lien F•••• L••• S•••••• D••• S•••+586, 1.00% F•••• M••••••• D••• 04/01/27 | $17.5M | $17.5M 100c | S+586 bp |
| M••••• F•••••••• I••••••••• C••• | revolver first lien F•••• L••• S•••••• D••• - R••••••• S•••+411, 1.00% F•••• M••••••• D••• 04/01/27 | $1.0M | $500,000 101c | S+411 bp |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | Not disclosed | |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | $18.0M 100c | |
| M••••• F•••••••• I••••••••• C••• | unstated lien unstated | Not disclosed | Not disclosed |
Capital structure as the BDCs see it
latest quarter end Mar 31, 2024
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Mar 31, 2024 | at least $17.5M | 100c | S+586 bp | Apr 1, 2027 | 1 |
| first lien revolver first lien exited Mar 31, 2024 | at least $1.0M | 101c | S+411 bp | Apr 1, 2027 | 1 |
Equity pieces beside the debt: other ($18.0M fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2024 | 1 | $18.5M | $18.0M | 100c | 0 |
| Dec 31, 2023 | 1 | $18.5M | $12.8M | 100c | 0 |
| Sep 30, 2023 | 1 | $1.0M | $0 | 0c | 0 |
| Jun 30, 2023 | 1 | $18.5M | $12.3M | 100c | 0 |
All 6 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Mar 31, 2023 | 1 | $18.5M | $12.3M | n/a | 0 |
| Dec 31, 2022 | 1 | $37.0M | $24.5M | 201c | 0 |
What changed
- Facility left every BDC scheduleMar 31, 2024
- Facility left every BDC scheduleMar 31, 2024
- New borrower on a BDC scheduleDec 31, 2022
Sponsor
Possible relationship, not established: R• C••••••, because a company of this name is on the sponsor's portfolio page (confidence 0.5). No deal announcement or filing names it as a party, so it is not shown as this borrower’s sponsor.
- R• C••••••
- the sponsor's own portfolio page lists a company of this nameestimatedrccf.com"••• Locked"
Identity
- Group key
- TISSUETECHderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it